19th Jul 2016 18:25
GlaxoSmithKline plc (the 'Company')
Transaction notification
1. | Details of PDMR/person closely associated with them ('PCA') | |||||||||||||||||
a) | Name | Sir Andrew Witty | ||||||||||||||||
b) | Position/status | CEO | ||||||||||||||||
c) | Initial notification/ amendment | Initial notification | ||||||||||||||||
2. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||||||||||||||
a) | Name | GlaxoSmithKline plc | ||||||||||||||||
b) | LEI | 5493000HZTVUYLO1D793 | ||||||||||||||||
3. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted | |||||||||||||||||
a) | Description of the financial instrument | Ordinary shares of 25 pence each ('Ordinary Shares')
ISIN: GB0009252882 | ||||||||||||||||
b) | Nature of the transaction | Increase in notional interest in Ordinary Shares following the re-investment of dividends paid to shareholders on 14 July 2016 on Ordinary Shares held in the Company's 2009 Performance Share Plan. | ||||||||||||||||
c) | Price(s) and volume(s) |
| ||||||||||||||||
d) | Aggregated information
Aggregated volume Price |
17,475.826 £16.285 | ||||||||||||||||
e) | Date of the transaction | 2016-07-14 | ||||||||||||||||
f) | Place of the transaction
| n/a | ||||||||||||||||
Related Shares:
Glaxosmithkline